RMD Resmed PE ratio, current and historical analysis
- Stocks
- Healthcare
- NYSE: RMD
- PE Ratio
The PE ratio for Resmed stock stands at 27.16 as of May 23, 2025. This is calculated based on the TTM EPS of $8.94 and the stock price of $242.84 per share. A decrease of 2.9% has been observed in the PE ratio compared to its average of 28.0 of the last four quarters.
RMD PE ratio history
Over the last ten years, the average PE ratio of Resmed has been 38.32. The current 27.16 P/E ratio is 29% lower than the historical average. Looking back at the last ten years, RMD's PE ratio peaked in the Sep 2021 quarter at 76.39, with a price of $263.55 and an EPS of $3.45. The Sep 2015 quarter marked the lowest point at 20.3, with a price of $50.96 and an EPS of $2.51.
Resmed PE ratio by year
Maximum annual increase: 69.23% in 2021
Maximum annual decrease: -47.92% in 2022
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| 2024 | 27.58 | -22.75% | $191.42 | $6.94 |
| 2023 | 35.7 | -9.07% | $218.5 | $6.12 |
| 2022 | 39.26 | -47.92% | $209.63 | $5.34 |
| 2021 | 75.39 | 69.23% | $246.52 | $3.27 |
| 2020 | 44.55 | 3.32% | $192 | $4.31 |
| 2019 | 43.12 | -8% | $122.03 | $2.83 |
| 2018 | 46.87 | 45.65% | $103.58 | $2.21 |
| 2017 | 32.18 | 27.75% | $77.87 | $2.42 |
| 2016 | 25.19 | 12.15% | $63.23 | $2.51 |
| 2015 | 22.46 | 8.24% | $56.37 | $2.51 |
| 2014 | 20.75 | -1.14% | $50.63 | $2.44 |
| 2013 | 20.99 | 17.72% | $45.13 | $2.15 |
| 2012 | 17.83 | -14.16% | $31.2 | $1.75 |
| 2011 | 20.77 | -13.92% | $30.95 | $1.49 |
| 2010 | 24.13 | 14.96% | $30.41 | $1.26 |
Resmed PE ratio by quarter (TTM)
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| Mar 2025 | 25.04 | -7.05% | $223.85 | $8.94 |
| Dec 2024 | 26.94 | -16.57% | $228.69 | $8.49 |
| Sep 2024 | 32.29 | 17.08% | $244.12 | $7.56 |
| Jun 2024 | 27.58 | -9.19% | $191.42 | $6.94 |
| Mar 2024 | 30.37 | 6.97% | $198.03 | $6.52 |
| Dec 2023 | 28.39 | 18.44% | $172.02 | $6.06 |
| Sep 2023 | 23.97 | -32.86% | $147.87 | $6.17 |
| Jun 2023 | 35.7 | -3.98% | $218.5 | $6.12 |
| Mar 2023 | 37.18 | -1.22% | $218.99 | $5.89 |
| Dec 2022 | 37.64 | -7.24% | $208.13 | $5.53 |
| Sep 2022 | 40.58 | 3.36% | $218.3 | $5.38 |
| Jun 2022 | 39.26 | -13.39% | $209.63 | $5.34 |
| Mar 2022 | 45.33 | -37.53% | $242.51 | $5.35 |
| Dec 2021 | 72.56 | -5.01% | $260.48 | $3.59 |
| Sep 2021 | 76.39 | 1.33% | $263.55 | $3.45 |
RMD Price vs fair value
RMD average PE ratio chart
Currently, RMD's PE ratio is lower than its 3, 5 and 10-year averages.
RMD PE vs peers
RMD's PE ratio stands higher than its peer stocks TMO and MDT.
| Stock name | PE ratio | Market cap |
|---|---|---|
| TMO Thermo Fisher Scientific Inc | 23.62 | $152.4B |
| ELMD Electromed Inc | 24.49 | $170.49M |
| MDT Medtronic plc | 24.6 | $104.44B |
| RMD Resmed Inc | 27.62 | $36.2B |
| MASI Masimo Corp | N/A | $8.46B |
| INGN Inogen Inc | N/A | $178.8M |
Frequently asked questions
What is Resmed's PE ratio?
RMD's price to earnings ratio is 27.16 as of May 23, 2025.
What is the 3-year average PE ratio for Resmed (RMD)?
As an average over the last 3 years, RMD stock has a PE ratio of 32.08.
What is the 5-year average PE ratio for Resmed (RMD)?
As an average over the last 5 years, RMD stock has a PE ratio of 42.05.
What is the highest PE ratio for RMD?
Over the last ten years, the Sep 2021 quarter recorded the highest quarterly PE ratio at 76.39.
How does the current PE ratio for RMD compare to its historical average?
The current PE ratio of RMD is 29% lower than the 10-year historical average.
How is RMD's PE ratio calculated (Resmed PE ratio formula)?
You can calculate the P/E ratio by dividing the most recent stock price by the trailing twelve months EPS. As of today (May 23, 2025), Resmed's share price is $242.84. The company's earnings per share for the trailing twelve months (TTM) ending Mar 2025 is $8.94. Therefore, Resmed's PE ratio for today is 27.16. PE RATIO(27.16) = STOCK PRICE($242.84) / TTM EPS($8.94)
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified.